About: Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.86 (-0.41%)
NUVB NYSE Nuvation Bio Inc
Nuvation Bio Inc share price
NUVB price activity
Last Price
$4.860
Change (24hr)
-0.02 USD (-0.41%)
Volume
5.45M
Volume (4w avg)
-
Open
$4.81
Day Range
$4.79 - $4.95
Previous Close
$4.88
Last Trade
07 Oct, 8:06 pm GMT+0
Delayed
07 Oct, 8:06 pm GMT+0
NUVB price performance
Delayed
07 Oct, 8:06 pm GMT+0
NUVB Market Signals